Optrell mapping RVOT PVC today. Successful with quickly pinning down PVC location.
Thanks to @BiosenseWebster for their technology. One more tool to help our patients!
Does anyone place external monitors in an inpatient setting as a patient is being discharged from their procedures or admissions? And are you able to bill for the hook up of the monitor?
1
142
RCavalcanti retweeted
This new commercial from Mothers Against Greg Abbott is one of the best political ads I’ve ever seen.
In patients with symptomatic atrial fibrillation at high risk for CVA who cannot be/won't take anticoagulants, no LAAO, and symptoms are well controlled on antiarrhthmics, do you leave them on AAD or stop since no longer getting recommended stroke prophylaxis?
0%Stop aad
100%Continue aad
4 votes • Final results RCavalcanti retweeted
Attention @HRSonline, @ACCinTouch! On 1/1/22, @CMSGov will cut reimbursement for #ablations by 30%. Reps Rush (D-IL) & Bilirakis (R-FL) introduced legislation to stop this. Click on link below to email your US rep to support you #EPeeps and your patients:
act.newmode.net/action/uspa_… – at Fort Lauderdale, FL
RCavalcanti retweeted
Which one of your colleagues does this remind you of, @ECGdoc44 ?!😂
RCavalcanti retweeted
Highly memorable day today at #HRS2021. Thank you to all PAUSE investigators for 6 yrs of unprecedented collaboration. 🙏
🇺🇸🇨🇳🇯🇵🇰🇷🇹🇼 #GlobalEP
VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD | tctmd.com #ablateVT tctmd.com/news/vt-no-matter-…
RCavalcanti retweeted
LBBAP did better compared to RV myocardial pacing in patients with bradycardia in presented study which included 703 patients!!! Congratulation to @psharmadoc @Hisdoc1 and all collaborators.
RCavalcanti retweeted
Late breaker #HRS2021 PAUSE/SCD by @DrRoderickTung . First line VT ablation reduces composite primary outcome of VT recurrence CV hospitalization or death by 42%. Are we seeing that early interventions are the way to go? @netta_doc @gautamsand – at Boston, MA
RCavalcanti retweeted
sustained improvement in LVEF at 4 yrs in Catheter Ablation Versus Medication in Atrial Fibrillation and Systolic Dysfunction: CAMERA-MRI Study jacc.org/doi/10.1016/j.jacep… @JACCJournals
RCavalcanti retweeted
So pleased to présent EARLY-AF this morning @AHAMeetings
- Largest first line ablation study.
- Continuous monitoring in all.
- Aggressive AAD use.
- No cross-overs.
@CANet_nce @HeartandStroke @UBCDoM @VCHResearch @UBCmedicine @CCI_CIC @ScienceVancity
nejm.org/doi/full/10.1056/NE…
















